Arrhythmia Research Technology, Inc. (NYSEMKT:HRT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain  Officers; Compensatory Arrangements of Certain Officers.



On December 28, 2016, Arrhythmia Research Technology, Inc. (the “Company”) entered into at-will employment agreements with Mr. Salvatore Emma, Jr. and Mr. Derek T. Welch, replacing the employment agreements terminating by their terms on December 31, 2016.   to the employment agreements, Mr. Emma and Mr. Welch will, respectively, continue to serve as the Chief Executive Officer and Chief Financial Officer of the Company and Micron Products, Inc. commencing effective as of January 1, 2017 and continuing thereafter unless terminated by either the Company or the executive officer with or without notice, and with or without cause, to the terms of the respective agreements.



to the respective agreements, Mr. Emma and Mr. Welch will be entitled to a base salary at the annualized rate of $247,500 and $170,000,  respectively, be eligible for compensation under the previously adopted Executive Incentive Plan and to participate in the Company’s other benefit plans.  The agreements contain certain change of control provisions providing for payment equivalent to 24 months of base salary at the rate then in effect and confidentiality, non-compete and non-solicitation restrictions.















About Arrhythmia Research Technology, Inc. (NYSEMKT:HRT)

Arrhythmia Research Technology, Inc. is a contract manufacturing organization. The Company, through its subsidiary, Micron Products, Inc. (Micron), produces medical device technologies requiring precision machining and injection molding. Micron provides design, engineering, quality and regulatory expertise across the Company’s product lines, including machining, plastic injection molding and sensors. It manufactures replacement knee systems, including femorals, tibial trays, inserts and instrumentation from investment castings (F-75, stainless steel), ultra-high-molecular-weight polyethylene (UHMWPE), ultrasonic cleaning and passivation. Its plastic injection molding services include clean room molding and tight tolerance specifications of engineered materials. It provides its customers with services, including the design, manufacture and rehabilitation of injection molding tools. Micron is a manufacturer and distributor of silver-plated and non-silver plated conductive resin sensors.

Arrhythmia Research Technology, Inc. (NYSEMKT:HRT) Recent Trading Information

Arrhythmia Research Technology, Inc. (NYSEMKT:HRT) closed its last trading session down -0.10 at 3.75 with 60,144 shares trading hands.